Compare GEG & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GEG | INCR |
|---|---|---|
| Founded | 1994 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.9M | 58.6M |
| IPO Year | 2022 | 2021 |
| Metric | GEG | INCR |
|---|---|---|
| Price | $2.16 | $4.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.0K | 3.3K |
| Earning Date | 11-11-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,974,000.00 | N/A |
| Revenue This Year | N/A | $203.61 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 11.70 | N/A |
| 52 Week Low | $1.80 | $0.68 |
| 52 Week High | $2.83 | $6.10 |
| Indicator | GEG | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 45.82 | 40.84 |
| Support Level | $2.10 | $0.81 |
| Resistance Level | $2.24 | $5.58 |
| Average True Range (ATR) | 0.01 | 0.21 |
| MACD | 0.00 | -0.13 |
| Stochastic Oscillator | 25.00 | 7.77 |
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. The Group conducts its operations through two business segments: Alternative Credit and Real Estate. Key revenue comes from the Real Estate segment, which includes a full-service, end-to-end real estate platform combining investment expertise and turnkey execution capabilities for the IOS sector. The Alternative Credit segment focuses on income generation and capital preservation by investing in debt and income-generating securities, direct lending, CLOs, and specialty finance businesses, including factoring, asset-based lending, and healthcare.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.